Literature DB >> 19104768

[Value of the postoperative Störkel score. Predict disease-free survival of patients with surgically resected renal cell carcinoma].

M May1, S Brookman-Amissah, S Pflanz, N Knoll, J Roigas, S Gunia, B Hoschke, F Kendel.   

Abstract

OBJECTIVE: To determine the value of clinical and pathological parameters defining the Störkel score in order to predict outcomes of patients with surgically treated renal cell carcinoma (RCC).
MATERIAL AND METHODS: A total of 834 consecutive patients having radical or partial nephrectomy were retrospectively reviewed. For each patient with RCC, the prognostic Störkel score was calculated according to the following variables: Robson stage, Thoenes nuclear grading, histological type, pattern of growth, and age. Based on the Störkel score, patients were divided into groups: those with good prognosis (GP), intermediate prognosis (IP), and poor prognosis (PP). Cancer-specific survival (CSS) and overall survival (OS) were estimated using the Kaplan-Meier method. The accuracy of prediction of CSS and OS with the Störkel score was analyzed using Kaplan-Meier analysis, proportional hazards regression, and graphic representation [(Kaplan-Meier curves, area under the curve (AUC)]. In 564 patients who were still alive, the median follow-up was 79 months (mean 84.8 months).
RESULTS: In the GP, IP, and PP groups, CSS after 8 years was 86.7%, 75.6%, and 13.7%, respectively (p<0.001). In the multiple analysis, only the Robson stage and Thoenes nuclear grading independently predicted CSS. Accordingly, the prognostic accuracy of the Störkel score (CSS prediction: AUC=0.744, 95% CI=0.70-0.79) was not better than with a reduced model that included the Robson stage and grading only (CSS prediction: AUC=0.765, 95%CI=0.72-0.81).
CONCLUSIONS: Of all parameters included in the Störkel score, only the Robson stage and nuclear grading are significant prognostic factors. Hence, we recommend an accordant modification of the score with additional variables.

Entities:  

Mesh:

Year:  2009        PMID: 19104768     DOI: 10.1007/s00120-008-1912-1

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  24 in total

1.  Prognostic factors and survival after pulmonary resection of metastatic renal cell carcinoma.

Authors:  Hans-Stefan Hofmann; Heinz Neef; Katharina Krohe; Petko Andreev; Rolf-Edgar Silber
Journal:  Eur Urol       Date:  2005-03-20       Impact factor: 20.096

2.  Comparison of preoperative embolization followed by radical nephrectomy with radical nephrectomy alone for renal cell carcinoma.

Authors:  H Zielinski; S Szmigielski; Z Petrovich
Journal:  Am J Clin Oncol       Date:  2000-02       Impact factor: 2.339

3.  Postoperative surveillance protocol for patients with localized and locally advanced renal cell carcinoma based on a validated prognostic nomogram and risk group stratification system.

Authors:  John S Lam; Oleg Shvarts; John T Leppert; Allan J Pantuck; Robert A Figlin; Arie S Belldegrun
Journal:  J Urol       Date:  2005-08       Impact factor: 7.450

4.  Outcome of surgical treatment of isolated local recurrence after radical nephrectomy for renal cell carcinoma.

Authors:  Steffen Schrodter; Oliver W Hakenberg; Andreas Manseck; Steffen Leike; Manfred P Wirth
Journal:  J Urol       Date:  2002-04       Impact factor: 7.450

5.  Chromophobe renal cell carcinoma: comprehensive analysis of 104 cases from multicenter European database.

Authors:  Luca Cindolo; Alexandre de la Taille; Luigi Schips; Richard E Zigeuner; Vincenzo Ficarra; Jacques Tostain; Walter Artibani; Antonio Gallo; Luigi Salzano; Jean-Jacques Patard
Journal:  Urology       Date:  2005-04       Impact factor: 2.649

6.  Impact of clinicopathological parameters in patients treated for renal cell carcinoma.

Authors:  Marcos F Dall'Oglio; Marco A Arap; Alberto A Antunes; Jose Cury; Kátia R Leite; Miguel Srougi
Journal:  J Urol       Date:  2007-05       Impact factor: 7.450

7.  A multifactorial postoperative surveillance model for patients with surgically treated clear cell renal cell carcinoma.

Authors:  Igor Frank; Michael L Blute; John C Cheville; Christine M Lohse; Amy L Weaver; Bradley C Leibovich; Horst Zincke
Journal:  J Urol       Date:  2003-12       Impact factor: 7.450

8.  Microvascular tumor invasion, tumor size and Fuhrman grade: a pathological triad for prognostic evaluation of renal cell carcinoma.

Authors:  Marcos F Dall'Oglio; Leopoldo Alves Ribeiro-Filho; Alberto A Antunes; Alexandre Crippa; Luciano Nesrallah; Pierre D Gonçalves; Kátia R M Leite; Miguel Srougi
Journal:  J Urol       Date:  2007-06-11       Impact factor: 7.450

9.  Kidney cancer.

Authors:  Eric M Wallen; Raj S Pruthi; Geoffrey F Joyce; Matthew Wise
Journal:  J Urol       Date:  2007-06       Impact factor: 7.450

10.  The value of transvascular embolization in the treatment of renal carcinoma.

Authors:  K Christensen; U Dyreborg; J F Andersen; H M Nissen
Journal:  J Urol       Date:  1985-02       Impact factor: 7.450

View more
  1 in total

1.  [Organ and kidney function preservation in renal cell carcinoma].

Authors:  M Schenck; R Eder; H Rübben; C Niedworok; S Tschirdewahn
Journal:  Urologe A       Date:  2014-09       Impact factor: 0.639

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.